Brief: EyeGate Pharmaceuticals Announces Management Transition In Support Of Strategic Transformation

Kiora Pharmaceuticals

01/02/2021 12:11

Feb 1 (Reuters) - EyeGate Pharmaceuticals Inc  EYEG.O :
    * EYEGATE PHARMACEUTICALS ANNOUNCES MANAGEMENT TRANSITION IN
SUPPORT OF STRATEGIC TRANSFORMATION
    * EYEGATE PHARMACEUTICALS INC - STEPHEN FROM ELEVATED FROM
CHIEF
EXECUTIVE OFFICER TO EXECUTIVE CHAIRMAN
    * EYEGATE PHARMACEUTICALS INC - FRANZ OBERMAYR APPOINTED AS
ACTING
CHIEF EXECUTIVE OFFICER
    * EYEGATE PHARMACEUTICALS - FRANZ OBERMAYR, APPOINTED AS
ACTING
CEO

Source text for Eikon:  ID:nGNX16RL4T 
Further company coverage:  EYEG.O 

 ((Reuters.Briefs@thomsonreuters.com;))